Skip to main content
Sponsored

European legislation must be revised to boost innovation in rare disease

This article has been developed and funded by Chiesi Group Rare Diseases.  Inflation and rising public debt are creating barriers for the rare disease community to access the latest therapies. Public healthcare budgets are being reduced, making access to new treatments difficult while stricter evidence requirements further limit availability across Europe. The lack of treatment … Continued
This highly detailed image presents orange glowing bacteria floating against a dark background, emphasizing microbial life and its constant presence in our surroundings
Rare Diseases 2025

Protected: From understanding to impact: driving academic research to deliver rare therapies

There is no excerpt because this is a protected post.
Rare Diseases Q3 2024

Cutting the rare disease diagnostic odyssey and customising treatments

Rare conditions are individually rare, but they are collectively common. This makes overcoming barriers to diagnosis and effective treatment especially vital. Three and a half million people in the UK live with a rare condition. Many face a long and difficult diagnosis journey, with less than 10% of conditions having a treatment. This presents two … Continued